GenSight Biologics Announces Annual General Meeting Details

GenSight Biologics, a company specializing in gene therapies for retinal and central nervous system disorders, has announced that its Annual General Meeting will take place on May 13, 2025. The meeting will start at 2:00 pm CEST at the company's headquarters in Paris, France. For wider accessibility, the meeting will be webcast live, allowing shareholders to join remotely.

Details about the meeting's agenda and draft resolutions were published in the French BALO and a legal gazette. Shareholders can access preparatory documents on the company's website or request them via email.

GenSight Biologics ensures transparency by making relevant documents available at their headquarters until shortly before the meeting. Shareholders can request these in line with French Commercial Code guidelines.